Register entry
Inventia Healthcare Limited.
- Registered sites
- 1
- Drug products
- 6
- Live patents
- 0
- Countries
- 1
- Base
- India
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingLabellingFinished drug manufacturePackaging
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Inventia Healthcare Limited | ThaneIndia | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3008232264 |
Catalogue
Marketed products
6Showing 6 of 6.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| OLMESARTAN MEDOXOMIL | olmesartan medoxomil | TABLET, COATED | ANDA |
| OLMESARTAN MEDOXOMIL | olmesartan medoxomil | TABLET, COATED | ANDA |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | TABLET, COATED | ANDA |
| duloxetine | duloxetine | CAPSULE, DELAYED RELEASE | ANDA |
| duloxetine | duloxetine | CAPSULE, DELAYED RELEASE | ANDA |
| duloxetine | duloxetine | CAPSULE, DELAYED RELEASE | ANDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.